Who Paid My Doc
Monovisc
Device Sports Early Intervention
PDI 10886705025183
General payments
$810,743
Research payments
$4,200
Through program year 2025, $810,743 in general payments and $4,200 in research payments were reported against Monovisc (Sports Early Intervention).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $157,414 | 3,892 |
| 2024 | General | $257,764 | 4,737 |
| 2023 | General | $156,499 | 3,418 |
| 2022 | General | $136,899 | 3,403 |
| 2022 | Research | $2,100 | 1 |
| 2021 | General | $102,168 | 3,237 |
| 2021 | Research | $2,100 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 72 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 47 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
18,687 general · 2 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.